tiprankstipranks
Trending News
More News >
Cytosorbents Corp (CTSO)
NASDAQ:CTSO
US Market
Advertisement

Cytosorbents (CTSO) Financial Statements

Compare
479 Followers

Cytosorbents Financial Overview

Cytosorbents's market cap is currently $65.11M. The company's EPS TTM is $-0.02; its P/E ratio is ―; Cytosorbents is scheduled to report earnings on May 14, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 35.59M$ 36.35M$ 29.36M$ 40.11M$ 39.45M
Gross Profit$ 25.13M$ 21.95M$ 15.40M$ 29.06M$ 28.40M
Operating Income$ -16.79M$ -31.21M$ -31.52M$ -22.75M$ -10.37M
EBITDA$ -19.26M$ -29.18M$ -30.00M$ -22.01M$ -9.71M
Net Income$ -20.72M$ -28.51M$ -32.81M$ -24.56M$ -7.84M
Balance Sheet
Cash & Short-Term Investments$ 3.28M$ 14.13M$ 22.14M$ 52.14M$ 71.42M
Total Assets$ 47.37M$ 53.26M$ 63.23M$ 89.52M$ 89.95M
Total Debt$ 26.89M$ 18.31M$ 18.25M$ 13.82M$ 1.03M
Net Debt$ 23.61M$ 4.18M$ -3.89M$ -38.32M$ -70.39M
Total Liabilities$ 36.26M$ 29.99M$ 27.86M$ 26.94M$ 10.73M
Stockholders' Equity$ 11.11M$ 23.28M$ 35.38M$ 62.58M$ 79.22M
Cash Flow
Free Cash Flow$ -14.71M$ -22.59M$ -34.69M$ -18.29M$ -7.29M
Operating Cash Flow$ -14.43M$ -21.66M$ -28.23M$ -14.01M$ -5.61M
Investing Cash Flow$ -669.43K$ -936.24K$ -6.46M$ -4.28M$ -1.68M
Financing Cash Flow$ 9.33M$ 14.47M$ 4.96M$ 715.20K$ 66.35M
Currency in USD

Cytosorbents Earnings and Revenue History

Cytosorbents Debt to Assets

Cytosorbents Cash Flow

Cytosorbents Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis